Montrose Environmental Group: MYndspan and MEGIN Revolutionize Access to Advanced MEG Brain Scanning Technology
- MYndspan partners with MEGIN to make advanced MEG brain scanning technology accessible to consumers.
- This collaboration aims to provide thorough brain health assessments, including functional brain age metrics.
- MYndspan's initiative promotes proactive cognitive health management, expanding MEG's application beyond clinical environments.
Transforming Brain Health: MYndspan and MEGIN Join Forces for Consumer Access to Advanced MEG Technology
In a groundbreaking partnership announced on February 27, 2025, MYndspan, a frontrunner in consumer brain health technology, teams up with MEGIN, a leading provider of magnetoencephalography (MEG) technology. This collaboration marks a significant step in democratizing access to high-precision brain scanning, with plans for a flagship MEG facility in London set to open later this year. By leveraging MEG technology, which is renowned for its ability to evaluate brain function with unparalleled accuracy—measuring the magnetic fields generated by neuronal activity—this initiative aims to make sophisticated brain health assessments available to the general public, rather than limiting them to clinical or research settings.
The partnership seeks to shift the paradigm of brain health monitoring, enabling individuals to gain insights into their cognitive wellbeing. Caitlin Baltzer, Co-Founder and CEO of MYndspan, emphasizes that this collaboration will facilitate the scaling of MEG technology beyond traditional healthcare environments. For the first time, consumers will be able to undergo MEG scans that provide thorough analyses of brain health, offering metrics such as functional brain age and indicators of potential neurodegenerative changes. This initiative aligns with MYndspan's mission to empower individuals to take proactive steps in managing their cognitive health, fostering a culture of preventative care.
Craig Shapero, CEO of MEGIN, highlights the significance of this partnership as a milestone in extending the utility of MEG technology. With MEGIN's extensive experience—more than 30 years in the field and a commanding 80% share of the global MEG market—the collaboration aims to establish MEG as a common tool for personal health management. Institutions such as Oxford and MIT have long utilized MEG for research on critical areas like cognition and epilepsy, but this partnership aims to broaden its application, bringing cutting-edge technology directly to consumers.
In addition to the MEG collaboration, MYndspan is also enhancing its precision neuroscience capabilities through a recent partnership with BIOS Health. This multi-faceted approach underscores the company’s ambition to revolutionize brain health management, blending advanced technology with consumer accessibility. As MYndspan rolls out consumer-focused MEG scans, it sets a new standard for how individuals can engage with their cognitive health, making advanced brain monitoring not just a luxury for researchers and clinicians but a viable option for everyday consumers.